Skip to main content
Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0096
+0.0003 (3.23%)
Aug 14, 2025, 3:59 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '12
Women Sexual and Reproductive Health
18.22M
Log In
Log In
Log In
Log In
Women Sexual and Reproductive Health Growth
8.20%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '12
United States
18.22M
Log In
Log In
Log In
Log In
United States Growth
8.20%
Log In
Log In
Log In
Log In